Cited by 74Bariatric Surgery and OutcomesAdipokines, Inflammation, and Metabolic DiseasesBody Contouring and Surgery

Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity

Netto, Bárbara Dal Molin, Bettini, Solange Cravo, Clemente, Ana Paula Grotti, de Carvalho Ferreira, Joana Pereira, Boritza, Katia, de Fátima Souza, Sandy, Von der Heyde, Maria Emilia, Earthman, Carrie P. +1 more·2015·Obesity Surgery

Abstract

Background The low-grade inflammatory state in obesity leads to insulin resistance and endothelial dysfunction, which promote cardiovascular diseases in individuals with obesity. The purpose of this study was to evaluate the early effects of weight loss achieved through bariatric surgery on the inflammatory and prothrombotic states. This study also aimed to identify the role of hyperleptinemia on the prothrombotic state.Methods The sample was composed of 41 extremely obese who underwent Roux-en-Y gastric bypass (RYGB). Anthropometric and clinical data, and biochemical markers of inflammation were collected prior to surgery and 6 months post-RYGB.Results It was found that plasminogen activator inhibitor-1 (PAI-1) concentrations were higher among extremely obese individuals with hyperleptinemia than in those without hyperleptinemia (p < 0.01).In relation to the baseline, post-surgery body mass index (BMI) was reduced by 12.9 kg/m(2), corresponding to 63.50 % of excess weight loss. Additionally, waist circumference was found to decrease significantly from 126.2 to 101.4 cm. Plasma total cholesterol (p < 0.01), LDL cholesterol (p = 0.02), triglycerides (p < 0.01), and glucose (p = 0.01) were also found to decrease. Pro-inflammatory biomarkers were observed to decrease: PAI-1 by 55.9 ± 6.0 % (p < 0.01), C-reactive protein (CRP) by 18.8 ± 3.4 % (p < 0.01), intercellular adhesion molecule-1 (ICAM-1) by 89.9 ± 5.7 % (p < 0.01), leptin by 27.9 ± 3.2 % (p < 0.01), and resistin by 69.3 ± 5.8 % (p < 0.01). Additionally, significant decreases of tumor necrosis factor alpha (TNF-α) and leptin/adiponectin ratio were observed. Anti-inflammatory cytokines adiponectin and interleukin-10 (IL-10) were significantly increased (170.7 ± 82.5 %, p < 0.01; 122.7 ± 55.1 %, p = 0.02). CRP levels were predictive of ICAM-1 (p = 0.04), and changes in leptin concentrations were associated with decreased PAI-1 levels (p = 0.03).Conclusions We observed that individuals with obesity that have hyperleptinemia have higher circulating PAI-1 levels, which could indicate increased risk for cardiovascular disease. The biomarkers of inflammation and thrombosis measured in this study decreased after RYGB, suggesting that the surgery may be effective in reducing pro-inflammatory and thrombotic risk in individuals with extreme obesity.

Integrity signals

Registry

Crossref · 10.1007/s11695-014-1484-7

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Weight-related reductions in PAI-1:Ag have previously been observed after bariatric surgery.

    “weight-related reductions in PAI-1:Ag are of potential interest and have previously been observed after bariatric surgery. 15,40”
  • Several reviews of bariatric surgery found that E-selectin and sICAM-1 decreased after surgery, although this was not always consistent for sICAM-1.

    “Several reviews of bariatric surgery found that E-selectin and sICAM-1 decreased after surgery, 15,39 although this was not always consistent for sICAM-1. 40”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Netto, B. D. M., Bettini, S. C., Clemente, A. P. G., de Carvalho Ferreira, J. P., Boritza, K., de Fátima Souza, S., Von der Heyde, M. E., Earthman, C. P., & Dâmaso, A. R.
Affiliations
  • Universidade Federal de São Paulo (BR)
  • Hospital de Clínicas Universidade Federal do Paraná (BR)
  • University of Minnesota (US)
Corresponding author
  • Netto, Bárbara Dal Molin
  • Dâmaso, Ana R.
Venue
Obesity Surgery
Published
2014-11-19
Volume
25
Issue
6
Pages
1010-1018
ISSN
  • 0960-8923 (ISSN-L)
  • 1708-0428
OpenAlex
W1986056701
Cited by
74
References
38
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 4 · 2017: 9 · 2016: 8 · 2015: 3
FWCI
6.61
Type
journal article
Language
en
Open access
closed
Locations
  • Obesity Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Surgery › Body Contouring and Surgery
Keywords
Roux-en-Y gastric bypass, morbid obesity
MeSH terms
Adult, C-Reactive Protein, Female, Humans, Inflammation, Insulin Resistance, Male, Middle Aged, Obesity, Triglycerides, Gastric Bypass, Biomarkers, Weight Loss, Body Mass Index, Interleukin-10, Treatment Outcome, Plasminogen Activator Inhibitor 1, Intercellular Adhesion Molecule-1, Leptin, Adiponectin, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review